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Abstract
The emergence of modernization coupled with sedentary lifestyle has resulted in the shift from the 
prevalence of diseases only due to under nutrition, to those caused by over nutrition. The augmen-
tation of non-communicable diseases, thus, imposes double burden of disease, impeding the health 
of a nation. This upsurge has led to increase in prevalence and incidence of Metabolic syndrome 
which is a cluster of inter-related factors characterized by high fasting blood glucose, increased le-
vel of triglycerides, low levels of high density cholesterol, elevated blood pressure and abdominal 
obesity. The best way to combat this syndrome is to reduce the atherosclerotic risk, which can be 
carried out by modification in the diet and lifestyle – the first line of treatment of the syndrome. 
Thus, the present review was undertaken to understand the already existing as well as the current 
scenario specifically regarding the dietary and lifestyle interventions being carried out to overcome 
Metabolic syndrome. Of the randomized control trials reviewed, all except one reported improve-
ment in Metabolic syndrome following intervention in diet and/or lifestyle modification either in 
certain components or overall syndrome within a period of 2 weeks–1 year. These interventions to 
alter diet and lifestyle focus on weight reduction, promotion of regular physical activity, reduction 
of substance abuse, effectiveness of specific food items along with regulation of genes and various 
inflammatory markers. They have the potential to succeed only if they are executed early, and thus, 
offer enough evidence to develop appropriate public policies. However, the issue that is of utmost 
significance is of sustainability and compliance, which eventually decides the long-term success or 
failure of an intervention.
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Introduction
With the advent of modernization, subsequent development of new facilities has led to sedentary li-
festyle and consumption of high caloric diet, leading to an imbalance between the energy intake and 
energy expenditure [1,2]. This has led to rise in obesity which leads to other co-morbidities such as 
hypertension, insulin resistance, dyslipidemia, and diabetes eventually leading to Metabolic Syndrome 
(MetS) which acts as a precursor to cardiovascular disease (CVD) [1,2]. With continuing under nu-
trition, and escalation in over nutrition, there is double burden of diseases (communicable and non-
communicable) hovering on nations especially the developing countries which do not have adequate 
resources [3,4]. The global prevalence of chronic diseases is on rise in the developing countries with a 
share of 60% alone [5]. They will be accountable for three quarters of deaths worldwide by 2020 with a 
share of 71% due to CVD and 70% due to diabetes mellitus (DM) in the developing countries [6]. India 
will continue to hold its position as the highest DM patients’ country in the world [7]. This increase 
in the prevalence of the non-communicable diseases (NCDs) currently as well as the high projected 
prevalence in the future is apprehensive. Strategizing public health policies and intervention programs 
is the top priority and need of the hour. Though pharmacological approach is one way of treating this 
problem, changes in the diet and lifestyle are the foremost hurdles that are needed to be crossed [8]. 
Therefore, the main objective of undertaking this review was to assess the effectiveness of dietary and 
lifestyle interventions in different population groups in overcoming MetS.
Methodology
In this article, we have reviewed the existing research regarding diet and lifestyle in treating or reducing 
MetS. We reviewed recent and past literature using Medline, PubMed (National Library of Medicine, 
Bethesda, MD, USA), Cochrane Library, Science Direct and Google Scholar databases. The keywords 
that were used included metabolic syndrome, diet, lifestyle, Mediterranean diet, intervention, insulin 
resistance, obesity, non- communicable diseases, hypertension, HDL, triglycerides, inflammation, ge-
netics, CRP. Published randomized control trials (RCTs) on the effect of dietary and lifestyle interven-
tions on MetS, which have been listed in the above mentioned databases from 2004 till 2012, have been 
included in this review.
Metabolic syndrome
Terminology and diagnostic criteria
The interrelationship between obesity, type 2 DM and hypertension includes hyperinsulineamia as its 
essential feature [9], which led to Reaven’s hypothesis that clustering of insulin resistance with glucose 
intolerance, hypertension, and dyslipidemia leads to a unique condition known as MetS or Syndrome X 
[10,11]. It is a cluster of interrelated factors characterized by high fasting blood glucose, increased level 
of triglycerides, low levels of high density lipoprotein (HDL), elevated blood pressure and abdominal 
obesity [12]. However the criteria for defining the syndrome are various (Table I).
Irrespective of the varying criteria proposed by different definitions, the prevalence of MetS is on the rise 
in both western as well as the Asian countries [1,13-15]. Increment in the proportion of diagnosed indi-
viduals can be related to increase in age as well as in body mass index (BMI) [16]. Not only the western 
societies, but also the developing countries are now getting engulfed in the burden of this problem. This 
Dia-
gnostic 
criteria
Expert group/Organization
WHO,  
1998
EGIR,  
1999
NCEP: ATPIII,  
2001
AACE,  
2003
AHA/NHLBI,  
2005
IDF,  
2005
Consensus 
definition,  
2005*
IFG >100 mg / dl 110 mg / dl 
or greater
110 mg / dl 
or greater
Impaired 
glucose 
tolerance
100 mg / dl 
or greater
100 mg / dl 
or greater
100 mg / dl 
or greater
WC M ≥ 94 cm,
W ≥ 80 cm
M > 102 cm,
W > 88 cm
M ≥ 102 cm, 
W ≥88 cm
BMI > 30 kg/ m2 
or elevated WC 
(according to 
population and 
country-specific 
definitions)#
Elevated WC 
(according to 
population and 
country-specific 
definitions)#
WHR M > 0.9, 
W > 0.85
BMI > 30 kg/m2 ≥ 30 kg/m2
TG TG ≥ 
150 mg / dl 
and/or
HDL-C: 
M < 40 mg / dl
W < 50 mg / dl
≥ 150 mg / dl 
and/or
HDL-C: 
< 39 mg / dl 
in M or W
≥ 150 mg / dl TG ≥ 
150 mg / dl 
and/or HDL-C: 
M < 40 mg / dl, 
W < 50 mg / dl
≥ 150 mg / dl ≥ 150 mg / dl 150 mg / dl or 
greater
HDL- C M < 40 mg / dl, 
W < 50 mg / dl
M < 40 mg / dl, 
W < 50 mg / dl
M < 40 mg / dl, 
W < 50 mg / dl
M < 40 mg / dl, 
W < 50 mg / dl
BP ≥ 140/90 
mmHg
≥ 140/90 
mmHg
≥ 130/85 
mmHg
≥ 130/85 
mmHg
≥ 130/85 
mmHg
≥ 130/85 
mmHg
≥ 130/85 
mmHg
Any 
other
- - - - - - Microalbuminuria 
≥ 20 μg/min or 
≥ 30 mg/g
Table I. Diagnostic criteria for Metabolic Syndrome
AACE = American Association of Clinical Endocrinology; AHA/NHLBI = American Heart Association/
National Heart, Lung, and Blood Institute; BMI = Body Mass Index; EGIR = European Group for the Study 
of Insulin Resistance; IDF = International Diabetes Federation; NCEP ATPIII = National Cholesterol Education 
Program Adult TreatMt Panel III; WC = waist circumference; WHR = Waist Hip ratio; WHO = World Health 
Organization
M = M; W = W
*Incorporating IDF and AHA/NHLBI definitions; IFG = impaired fasting glucose; TG = triglycerides; HDL- 
C = High Density Lipoprotein Cholesterol; BP = blood pressure
# Waist circumference: for Europeans, > 94 cm in M and > 80 cm in W; and for South Asians, Chinese, and 
Japanese, > 90 cm in M and > 80 cm in W. For ethnic South and Central Americans, South Asian data are used, and 
for sub-Saharan Africans and Eastern Mediterranean and Middle East (Arab) populations, European data are used
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rise can be attributed to the transition in the lifestyle from a traditional to a western one. The genesis of 
MetS and obesity in developing countries relates to demographic transition (shift to low fertility, low 
mortality, and higher life expectancy), and epidemiological transition (from widely prevalent infectious 
diseases to a pattern of a high prevalence of lifestyle related diseases) congregating genetics and envi-
ronment [17-20]. Abdominal obesity [21-23], insulin resistance [10,11], along with physical inactivity 
[22,24], aging [25], hormonal imbalance [26], and atherogenic diet (a diet rich in saturated fat and cho-
lesterol) are some factors that can exacerbate the risk for developing MetS, and consequently CVD [12].
Prevalence and risk factors
MetS is present worldwide, continuing to rise, with many countries now facing its burden [27]. Accor-
ding to the Framingham study, 25% of new cases of CVD are accounted by MetS. Prevalence of MetS 
is on the rise in the developing countries (affecting nearly ¼th of the populations), including India. 
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CVD accounted for 39% of deaths in India, attributing it to be the leading cause of mortality in 2005 
[27]. Not only urban but rural populations are also being affected by it [28-30]. Prevalence of MetS is 
widespread, as can be observed through literature available over the years. There is not only an incre-
asing trend in the South Asians residing in the Indian subcontinent but also in migrants [31], with an 
estimated prevalence of 20-25% [32]. The contributory factors for MetS (Table II) are age [33-37], sex 
[36,38-40], region [36,38,41,42], income [43-46], Adult Treatment Panel III (ATPIII) or International 
Diabetes Federation (IDF) criteria [17,47-49] and occupation [50,51]. In light of the evidence provided 
in Table II, it is clear that there exists an inverse relationship between income and MetS in developed 
countries [43,44,46]; however, the situation is reversed in the developing countries where the preva-
lence increases with the rise in socioeconomic status [38]. This can be attributed to the fact that in 
developing countries, as the income increases, more amount of the income is spent on fats and sugars; 
while in the developed countries, those with the lower income prefer to buy foods rich in fats and sugar 
as they are much cheaper than other food items. Though MetS portrays low prevalence among youth, 
clustering of risk factors can result in the progression towards the syndrome in adulthood, thus, advo-
cating early identification for alleviation of the problems related to the syndrome [52,53] is essential.
MetS is a challenging condition as it is not a discrete entity but consists of multitude of risk factors (Figu-
re 1). The risk varies in an individual depending on the aggregation of metabolic and non-metabolic risk 
factors [54]. According to the American Heart Association (AHA) statement [55], atherogenic dyslipide-
mia, elevated blood pressure, and elevated plasma glucose are the most familiar risk factors. Other factors 
include abdominal obesity [21-23], insulin resistance [10,11], along with physical inactivity [22,24], 
aging [25], hormonal imbalance [26], and atherogenic diet [12]. Relationship of MetS with sex, age, de-
gree of obesity and socio-economic status has also been confirmed [56,57]. Ethnicity [25,58,59], smoking 
[60,61,62], alcohol consumption [63-66], inflammation [67,68,37], genetic predisposition [69,70], low 
birth weight [71,72], polycystic ovary syndrome (PCOS), menopause, and hormone replacement therapy 
(HRT) [73] have also shown their association with the syndrome. A solitary factor cannot purport to 
augmentation of the syndrome; therefore, interaction amongst various domains relating to it, holds co-
lossal worth that needs to be evaluated with the help of longitudinal studies [27].
Treatment of Metabolic Syndrome
Pharmacological treatment
According to AHA [55], the targeted treatment for the syndrome underlines the fact that the foremost 
goal is to reduce the atherosclerotic risk. This involves directing attention at the major risk factors so 
Ref. Design & country Sample Finding(s)
[34] Cross-sectional, 
China
N=2,334 adults aged 60 to 
95 years (943 men, 1,391 
women)
 • Prevalence ATPIII criteria: 30.5% (17.6% in men, 39.2% in 
women)
 • Prevalence IDF criteria: 46.3% (34.8% in men, 54.1% in women)
 • Odds ratio for CVD, stroke and PAD are higher among those 
with MetS (irrespective of criterion)
[35] Cross-sectional, 
Australia
N=5,850 of which 
4,060 had biochemical 
examination
 • Prevalence IDF criteria: 22.8 (26.4% in men, 15.7% in women)
 • Prevalence ATPIII criteria: 15.0% (19.4% in men, 14.4% in 
women)
[36] Cross-sectional 
Jaipur, India 
(Urban)
N=1,091 (532 men; 559 
women) adults >20 years
 • Prevalence ATPIII criteria: 345 (31.6%) subjects – males 122 
(22.9%); females 223 (39.9%) (p<0.001)
 • Increase in prevalence with age (p<0.05)
[37] Prospective, 
Case-Control 
U.S.A
N= cases 32,826 women
N=785 controls
 • Baseline levels of TNF, IL, and CRP were significantly higher in 
cases than controls (P ≤ 0.001)
 • Significant association of CRP with risk of DM 
(OR: CRP = 3.99, P <0.001)
[38] Cross-sectional 
Chandigarh, India 
(Urban)
Adults aged 18 years and 
above
 • Prevalence IDF criteria: 287 adults (47.4%) – females 171 
(59.6%); males 116 (40.4%)
 • Prevalence ATPIII criteria: 233 adults (38.5%) – females 141 
(44.8%); males 116 (39.5%)
[41] Cross-sectional 
Toto tribe, Bhutia 
tribe
N=258 (Toto); 310 (Bhutia)  • Prevalence ATPIII criteria: 30-50% in Bhutia tribe; 4-9% in Toto 
tribe
 • MetS not necessarily related to modernization
[43] Cross-sectional 
London, U.K 
(High, Middle, 
Lower income)
N=1,509 women; 4,090 
men (aged 45.2-68.9 years)
 • Inverse association of own and household income and wealth 
with MetS (P<0.001).
 • Increased prevalence (WHO criteria) in men than women 
(wealthiest: 12.0 and 5.7%; poorest: 23.6 and 20.1%)
[44] Cross-sectional 
France, Europe
N=1,695 men; 
1,664 women, 
(aged 35-64 years)
 • Prevalence ATPIII criteria: 390 (23.0%) men; 381 (16.9%) 
women
 • Inverse association of household income with MetS (P<0.004) 
in women (Sex-specific increase)
[46] Cross-sectional
London, U.K 
(Income-wise 
stratification)
N=4978 men; 2035 women 
(aged 39-63 years)
 • Inverse association between obesity, fibrinogen and MetS, and 
socioeconomic status
[48] Cross-sectional
Zulia, Venezuela
N=3108 men and women 
(aged ≥20 years)
 • Prevalence ATPIII criteria: men 31.2%, women 24.1%
 • Family history of diabetes, obesity, HT and sedentary lifestyle 
were positively associated with the MS
[49] Cross-sectional
Muscat, Oman
N=1419 adults 
(aged ≥20 years)
 • Age adjusted prevalence ATPIII criteria: 21.0%; men 19.5%, 
women 23.0% (p=0.236)
[50] Cross-sectional
Pan-India 
(Industrial 
population)
N= 19,973 for 
questionnaire survey; 
10,442 biochemical testing 
(aged 20-69 years)
 • Prevalence ATPIII criteria: 26.6% (men 20.9%; women 36.3%)
 • Prevalence IDF criteria: 35.4% (men 29.4%; women 46.1%)
Table II. Prevalence of Metabolic Syndrome
Figure 1. Risk factors for Metabolic Syndrome [10,12,21,22,25,26,56,57]
HRT = Hormone Replacement Therapy; PCOS = Poly Cystic Ovary Syndrome
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that the treatment is offered to the patients’ relative to their risk. The first line of intervention is howe-
ver, the lifestyle therapies whether the risk is long or short term. To achieve maximum benefit, weight 
reduction through diet modification and increased physical activity results in risk reduction concur-
rently. Drug/pharmacological therapy isn’t syndrome specific but risk factor specified [55]. Drugs such 
as antihypertensive for controlling blood pressure, aspirin for those with a greater risk (more than 10% 
or 10 year risk) of developing the disease, and statins, fibrates and niacin for dyslipidemias are sugge-
sted in extreme cases where diet and lifestyle modification is not enough alone. However, maintenance 
of blood glucose levels with haemoglobin A1C level of less than 7.0% has been the key recommendation 
[55]. Nonetheless, the foundation of treatment for MetS is diet and lifestyle modification.
Dietary modification
Modernization in the field of agriculture has led to changes in the diet which alongside a sedentary li-
festyle has contributed to increased consumption of diets rich in fat and cholesterol leading to an ove-
rall positive energy balance [74]. Therefore, poor diet is an important component of the syndrome that 
needs to be targeted for its reduction and treatment. The efficacy of Mediterranean diet (MeD) on MetS 
has been observed through many studies [75-79]. The Mediterranean Dietary pattern typically empha-
sizes fruits, cooked vegetables and legumes, grains (whole, not refined) and, in moderation, wine, nuts, 
fish and dairy products, particularly yogurt and cheese. It is a food pattern that has the potential of 
improving health and quality of life in people who adhere to it appropriately characterizing a way of life 
and culture [80]. Specifically, each component of Mediterranean dietary pattern has its own significan-
ce that holds a key in obviating MetS. Various dietary interventions have confirmed its role in MetS 
management (Table III), where they have shown significant weight loss, improvement in the MetS 
components [75,81], improvement in body composition and cardio-metabolic fitness [82], increase in 
long chain N3 poly unsaturated fatty acids [79] and decrease in high sensitive C-reactive protein (hs-
CRP) and insulin resistance [83].
A cross-sectional study with the participants (n=808 adults with high CVD risk) of the PREDIMED 
trial was conducted to understand the relationship between MeD and MetS. Negative association 
of the syndrome with high MeD score (≥9 points) was observed (p<0.001; OR=0.44) with specific 
components conferring conclusive benefits like olive oil, legumes and red wine [84]. Following this, 
the PREDIMED study investigators compared the effect of 2 interventions using MeD with a low fat 
diet on MetS with 1 year clinical trial [85]. MeD diet + 1 l/wk of virgin olive oil, MeD diet + 30 g/
day of mixed nuts and advice on low fat diet (control) was given, wherein MetS was defined using 
ATPIII criteria. After adjustment for age, sex, weight changes and baseline obesity status, the odds 
ratio (OR) for MetS decline was more for the nuts group (OR=1.7) than for the virgin olive oil group 
(OR=1.3), substantiating the importance of MeD diet as a useful tool in MetS management. Simi-
larly, women diagnosed with MetS in Korea (n=52; mean age, 62.7 ± 9.0 years) were subjected to a 
therapeutic lifestyle management program for 6 months. It included health monitoring, counselling, 
health education, exercise, and dieting as its components alongside measuring health related Quality 
of Life (QOL) index and metabolic risk factors at baseline, 3, 6 and 12 months. The program exhi-
bited significant reductions in body weight (p<0.001), waist circumference (WC) (p<0.001), general 
(p<0.001) and mental health (p=0.027), and vitality (p=0.008); with decrement in body weight and 
WC even sustaining after intervention. Another ongoing trial in Spain is being carried out to lessen 
the incidence of MetS, which is apparently on the rise [86]. The reduction of the metabolic syndrome 
in Navarra-Spain (RESMENA-S) study is a randomized prospective parallel design (n=50) encom-
passing personalized weight loss (30% energy restriction) diet, with a macronutrient distribution 
(carbohydrate/fat/protein) of 40/30/30, high meal frequency (7/day), low glycemic index/load and 
high antioxidant capacity as well as a high adherence to the MeD aimed to lower the incidence of the 
syndrome [86].
Ref. Country Sample Intervention Finding(s)
[75] Spain N=45 
sedentary 
adults 
(50-66 years)
Two groups: (a) hypocaloric, 
normoproteic MeD; and (b) 
the same diet plus periodized 
moderate-to-high intensity training 
(MeDE) for 12 weeks
 • Significant weight loss and improvement 
in MetS components was achieved with 
hypocaloric, normoproteic Mediterranean diet 
(p<0.05)
 • More significant weight loss was achieved 
with the combination of MeD and moderate 
intensity physical activity post 12 weeks 
compared to MeD alone (p<0.05)
[76] U.S.A Women; 
n=44 control; 
n=45 
intervention
Control (Mediterranean-style low-
glycemic-load diet) vs. intervention 
(diet + Medical food containing 
phytosterols, soy proteins
 • Decreases in fat and sugar intake (p<0.001), 
and increase in DHA and EPA (p<0.001) were 
observed in both groups
 • Significant reduction in all components of MetS 
(p<0.05) and plasma homocysteine levels was 
seen in the diet + medical food group (p<0.01) 
as compared to diet only group
[79] Germany N=101 adults Med diet group + 100 hrs of 
education (n=48) vs. written advice 
only group (n=53)
 • Increase in the consumption of fish, fruits/
vegetables and moderately of canola/olive oil 
and increased plasma concentrations of long-
chain n-3 polyunsaturated fatty acids in the 
intervention group
 • No change in the markers of inflammation like 
hs-CRP, fibrinogen, fasting insulin, homocysteine, 
serum lipids and plasma fatty acids
[81] Houston, 
Texas, 
USA
N=81 (22 
men)
12 week, 3 groups: 0, 8, or 16 fluid 
ounces of low sodium vegetable 
juice
 • More weight loss, high consumption of Vitamin 
C, potassium, and dietary vegetables was 
observed in the juice drinking group (p<0.05) 
compared to those only on diet counselling
[82] Whyalla, 
South 
Australia
N=153 obese 
adults with 
MetS
Randomized to intervention or 
control for 16 weeks. INT group: 
lifestyle program which provided a 
curriculum and practical strategies 
on 1) dietary and Physical Activity 
information based on national 
guidelines, 2) behavioural self-
management tools, 3) food-label 
reading, supermarkets tour and 
cooking, 4) exercise sessions, and 
5) peer-group support
 • Significant improvement observed in body 
composition (p<0.01), physical and cardio-
metabolic fitness (p<0.01) with minimally 
prescriptive lifestyle intervention program
[83] Naples, 
Italy
N = 180 
adults (99 
men and 81 
women) with 
MetS (ATPIII 
criteria): 90 
in control 
and 90 in 
intervention 
group
Patients in the intervention 
group were instructed to follow 
a Mediterranean-style diet and 
received detailed advice about how 
to increase daily consumption of 
whole grains, fruits, vegetables, 
nuts, and olive oil; patients in the 
control group followed a prudent 
diet (carbohydrates, 50-60%; 
proteins, 15-20%; total fat, <30%)
 • Post 2 years significant increase in fruit, 
vegetables, whole grains, olive oil and nuts 
consumption (p<0.001), and decrease in mean 
body weight was observed in the intervention 
group (p<0.001)
 • Significant improvement in the endothelial 
function score (p<0.001) and reduction in the 
hs-CRP values (p=0.01) and insulin resistance 
(p<0.001) was also observed in the intervention 
group
[134] U.S.A N = 54 
normal 
weight young 
women; 18 
to 31 years
Two year exercise intervention. 
Three sessions of resistance exercise 
plus 60 minutes of jumping rope 
per week or a control group for 24 
months + dietary assessment for Ca 
intake using a 3 day diet record
 • High Ca intake led to lower weight gain and 
body fat after 2 years of intervention, regardless 
of the exercise group allocation
Table III. Effectiveness of RCTs to control Metabolic Syndrome
Ca = Calcium; DHA = Decosa Hexanoic Acid; EPA = Eicosa Pentanoic Acid; hs-CRP = High sensitive C Reactive 
Protein; MeD = Mediterranean Diet; MeDE = Mediterranean Diet + Exercise; MetS = Metabolic Syndrome
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that the treatment is offered to the patients’ relative to their risk. The first line of intervention is howe-
ver, the lifestyle therapies whether the risk is long or short term. To achieve maximum benefit, weight 
reduction through diet modification and increased physical activity results in risk reduction concur-
rently. Drug/pharmacological therapy isn’t syndrome specific but risk factor specified [55]. Drugs such 
as antihypertensive for controlling blood pressure, aspirin for those with a greater risk (more than 10% 
or 10 year risk) of developing the disease, and statins, fibrates and niacin for dyslipidemias are sugge-
sted in extreme cases where diet and lifestyle modification is not enough alone. However, maintenance 
of blood glucose levels with haemoglobin A1C level of less than 7.0% has been the key recommendation 
[55]. Nonetheless, the foundation of treatment for MetS is diet and lifestyle modification.
Dietary modification
Modernization in the field of agriculture has led to changes in the diet which alongside a sedentary li-
festyle has contributed to increased consumption of diets rich in fat and cholesterol leading to an ove-
rall positive energy balance [74]. Therefore, poor diet is an important component of the syndrome that 
needs to be targeted for its reduction and treatment. The efficacy of Mediterranean diet (MeD) on MetS 
has been observed through many studies [75-79]. The Mediterranean Dietary pattern typically empha-
sizes fruits, cooked vegetables and legumes, grains (whole, not refined) and, in moderation, wine, nuts, 
fish and dairy products, particularly yogurt and cheese. It is a food pattern that has the potential of 
improving health and quality of life in people who adhere to it appropriately characterizing a way of life 
and culture [80]. Specifically, each component of Mediterranean dietary pattern has its own significan-
ce that holds a key in obviating MetS. Various dietary interventions have confirmed its role in MetS 
management (Table III), where they have shown significant weight loss, improvement in the MetS 
components [75,81], improvement in body composition and cardio-metabolic fitness [82], increase in 
long chain N3 poly unsaturated fatty acids [79] and decrease in high sensitive C-reactive protein (hs-
CRP) and insulin resistance [83].
A cross-sectional study with the participants (n=808 adults with high CVD risk) of the PREDIMED 
trial was conducted to understand the relationship between MeD and MetS. Negative association 
of the syndrome with high MeD score (≥9 points) was observed (p<0.001; OR=0.44) with specific 
components conferring conclusive benefits like olive oil, legumes and red wine [84]. Following this, 
the PREDIMED study investigators compared the effect of 2 interventions using MeD with a low fat 
diet on MetS with 1 year clinical trial [85]. MeD diet + 1 l/wk of virgin olive oil, MeD diet + 30 g/
day of mixed nuts and advice on low fat diet (control) was given, wherein MetS was defined using 
ATPIII criteria. After adjustment for age, sex, weight changes and baseline obesity status, the odds 
ratio (OR) for MetS decline was more for the nuts group (OR=1.7) than for the virgin olive oil group 
(OR=1.3), substantiating the importance of MeD diet as a useful tool in MetS management. Simi-
larly, women diagnosed with MetS in Korea (n=52; mean age, 62.7 ± 9.0 years) were subjected to a 
therapeutic lifestyle management program for 6 months. It included health monitoring, counselling, 
health education, exercise, and dieting as its components alongside measuring health related Quality 
of Life (QOL) index and metabolic risk factors at baseline, 3, 6 and 12 months. The program exhi-
bited significant reductions in body weight (p<0.001), waist circumference (WC) (p<0.001), general 
(p<0.001) and mental health (p=0.027), and vitality (p=0.008); with decrement in body weight and 
WC even sustaining after intervention. Another ongoing trial in Spain is being carried out to lessen 
the incidence of MetS, which is apparently on the rise [86]. The reduction of the metabolic syndrome 
in Navarra-Spain (RESMENA-S) study is a randomized prospective parallel design (n=50) encom-
passing personalized weight loss (30% energy restriction) diet, with a macronutrient distribution 
(carbohydrate/fat/protein) of 40/30/30, high meal frequency (7/day), low glycemic index/load and 
high antioxidant capacity as well as a high adherence to the MeD aimed to lower the incidence of the 
syndrome [86].
Ref. Country Sample Intervention Finding(s)
[75] Spain N=45 
sedentary 
adults 
(50-66 years)
Two groups: (a) hypocaloric, 
normoproteic MeD; and (b) 
the same diet plus periodized 
moderate-to-high intensity training 
(MeDE) for 12 weeks
 • Significant weight loss and improvement 
in MetS components was achieved with 
hypocaloric, normoproteic Mediterranean diet 
(p<0.05)
 • More significant weight loss was achieved 
with the combination of MeD and moderate 
intensity physical activity post 12 weeks 
compared to MeD alone (p<0.05)
[76] U.S.A Women; 
n=44 control; 
n=45 
intervention
Control (Mediterranean-style low-
glycemic-load diet) vs. intervention 
(diet + Medical food containing 
phytosterols, soy proteins
 • Decreases in fat and sugar intake (p<0.001), 
and increase in DHA and EPA (p<0.001) were 
observed in both groups
 • Significant reduction in all components of MetS 
(p<0.05) and plasma homocysteine levels was 
seen in the diet + medical food group (p<0.01) 
as compared to diet only group
[79] Germany N=101 adults Med diet group + 100 hrs of 
education (n=48) vs. written advice 
only group (n=53)
 • Increase in the consumption of fish, fruits/
vegetables and moderately of canola/olive oil 
and increased plasma concentrations of long-
chain n-3 polyunsaturated fatty acids in the 
intervention group
 • No change in the markers of inflammation like 
hs-CRP, fibrinogen, fasting insulin, homocysteine, 
serum lipids and plasma fatty acids
[81] Houston, 
Texas, 
USA
N=81 (22 
men)
12 week, 3 groups: 0, 8, or 16 fluid 
ounces of low sodium vegetable 
juice
 • More weight loss, high consumption of Vitamin 
C, potassium, and dietary vegetables was 
observed in the juice drinking group (p<0.05) 
compared to those only on diet counselling
[82] Whyalla, 
South 
Australia
N=153 obese 
adults with 
MetS
Randomized to intervention or 
control for 16 weeks. INT group: 
lifestyle program which provided a 
curriculum and practical strategies 
on 1) dietary and Physical Activity 
information based on national 
guidelines, 2) behavioural self-
management tools, 3) food-label 
reading, supermarkets tour and 
cooking, 4) exercise sessions, and 
5) peer-group support
 • Significant improvement observed in body 
composition (p<0.01), physical and cardio-
metabolic fitness (p<0.01) with minimally 
prescriptive lifestyle intervention program
[83] Naples, 
Italy
N = 180 
adults (99 
men and 81 
women) with 
MetS (ATPIII 
criteria): 90 
in control 
and 90 in 
intervention 
group
Patients in the intervention 
group were instructed to follow 
a Mediterranean-style diet and 
received detailed advice about how 
to increase daily consumption of 
whole grains, fruits, vegetables, 
nuts, and olive oil; patients in the 
control group followed a prudent 
diet (carbohydrates, 50-60%; 
proteins, 15-20%; total fat, <30%)
 • Post 2 years significant increase in fruit, 
vegetables, whole grains, olive oil and nuts 
consumption (p<0.001), and decrease in mean 
body weight was observed in the intervention 
group (p<0.001)
 • Significant improvement in the endothelial 
function score (p<0.001) and reduction in the 
hs-CRP values (p=0.01) and insulin resistance 
(p<0.001) was also observed in the intervention 
group
[134] U.S.A N = 54 
normal 
weight young 
women; 18 
to 31 years
Two year exercise intervention. 
Three sessions of resistance exercise 
plus 60 minutes of jumping rope 
per week or a control group for 24 
months + dietary assessment for Ca 
intake using a 3 day diet record
 • High Ca intake led to lower weight gain and 
body fat after 2 years of intervention, regardless 
of the exercise group allocation
Table III. Effectiveness of RCTs to control Metabolic Syndrome
Ca = Calcium; DHA = Decosa Hexanoic Acid; EPA = Eicosa Pentanoic Acid; hs-CRP = High sensitive C Reactive 
Protein; MeD = Mediterranean Diet; MeDE = Mediterranean Diet + Exercise; MetS = Metabolic Syndrome
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Considering effectiveness of specific food items in MetS reduction, consumption of boiled artichoke 
meal had no beneficial effect in patients (n=19) with MetS in a RCT which was undertaken to ascer-
tain if artichoke could be beneficial in lowering the post – prandial glucose levels and insulin levels in 
MetS patients [87]. However, Lerman et al. [88] demonstrated benefits from a Mediterranean-style, 
low-glycemic-load diet (n=12) and phytochemical-enhanced diet (n=12) consumed over 12 weeks pe-
riod coupled with identical aerobic exercise counselling. The phytochemical-enhanced diet comprised 
of low-glycemic-load diet plus a medical food containing soy protein and plant sterols and a nutraceu-
tical containing hops rho iso-alpha acids and acacia proanthocyanidins. Improvement in the levels of 
total cholesterol, low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol 
(non-HDL-C), cholesterol/HDL-C, triglyceride/HDL-C, apolipoprotein B (apo B), apo B/apo A-1, ho-
mocysteine, total LDL particle number, and large HDL particle number were observed in the phytoche-
mical enhanced diet group compared to only Med diet group (p<0.05). Nuts, as a MeD component, have 
shown additional benefits regarding improvement of the syndrome, if incorporated along with lifestyle 
counselling. In a RCT [89] among 283 MetS screened patients, 30 g/d flaxseed or 30 g/d walnuts were gi-
ven with lifestyle counselling, while the third group received only counselling. Post 12 weeks, prevalence 
of the syndrome decreased significantly in all 3 groups. However, the severity was most significantly 
reduced in the walnuts group compared to only lifestyle counselling group (p=0.045). Similar reduction 
in MetS has also been observed with food containing phytosterols and soy proteins [76]. Therefore, spe-
cific foods such as nuts or phytochemicals might have a potential in prevention and management of the 
syndrome, however, more work is clearly warranted in this area to bring out their effectiveness.
Which is the best dietary composition to combat MetS?
Though diet and lifestyle modification seem to be the first line of treatment for the syndrome, the 
uncertainty with the exact diet composition for reduction of the syndrome still remains elusive [90]. 
Two diets viz. diet relatively rich in carbohydrate (65% of energy as carbohydrate, 13% as protein, and 
22% as fat: 17% as unsaturated fat) or a diet that was low in carbohydrate and high in protein and in 
monounsaturated fat (48% of energy as carbohydrate, 19% as protein, and 33% as fat: 24% as unsa-
turated fat), differing in their composition were tested on 100 obese patients with MetS. At the end 
of 5 months, though the syndrome components decreased in both diet groups, a greater significant 
decrease in hypertension (p<0.05) prevalence and hypertriacylglycerolemia (p< .001) were seen with 
the low carbohydrate (CHO) diet group [90]. Alleviation of the factors determining the syndrome was 
ascertained via a low calorie diet with or without exercise, in 323 overweight Japanese women (24-67 
years; BMI: 25-40 kg/m2) in a 3 months program. CART (Classification and regression tree) analysis 
revealed that a weight reduction of 8.1% in baseline body weight resulted in improvement of at least 1 
MetS component was observed among women ≤ 41.5 years; ≥ 13.0% weight loss led to improvement 
in abdominal obesity; improvement in blood pressure; ≥  13.2% weight loss led to improvement in 
hyperglycemia. Thus, a modest weight loss of 8-13% was nearly effective in ameliorating individual 
components of MetS in overweight Japanese women [91].
Dietary modification to counter the syndrome is also an important strategy to reduce cardiovascular 
risk. Four diets were randomly assigned to 337 patients: two high fat diets, one rich in saturated fat 
(HSFA) and the other rich in monounsaturated fat (HMUFA), and two low fat diets, one high in com-
plex carbohydrates (LFHCC) supplemented with 1.24 g/day of long-chain n-3 polyunsaturated fatty 
acids (LFHCC n-3) and the other LFHCC diet with placebo (LFHCC). Decrement in the prevalence 
of MetS (p<0.028), lowering of waist circumference, blood pressure and hypertriglyceridemia (p<0.05) 
was observed with the LFHCC n-3 diet in contrast to HSFA, HMUFA and LFHCC groups [92]. Meal 
replacement can also be an effective technique in reduction of MetS risk factors even over a short pe-
riod of time. Ninety overweight or obese subjects (45 years; BMI 31.5 ± 2.3 kg/m2) were either rando-
mized to a fat restricted low calorie diet group (LCD-G) (n=30) which received 2 dietary counselling 
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sessions and instructions on physical activity or in the meal replacement diet group (MRD-G) (n=60) 
that received the same lifestyle education and replaced 2 of their meals with low calories high protein 
soy drink. Subjects in the MRD-G lost significantly more weight (p<0.01), had higher reduction in 
WC (p<0.01), triglycerides (p<0.01), syndrome prevalence (p<0.05), leptin and insulin levels (p<0.01) 
in comparison to LCD-G [93]. Often, it becomes difficult to attribute exactly whether weight loss or 
behaviour change or both are responsible for successful reduction of the syndrome [94]. This pertinent 
aspect led to investigation in men and post menopausal women with elevated LDL and lowered HDL, 
to ascertain the effects of low fat diet and exercise – alone and in combination, on MetS. Maximum 
change in MetS was observed with low fat diet in men (p=0.04) and women (p=0.045) in comparison 
to controls. Yet, after adjustment for body fat change, there wasn’t any effect of low fat diet and exercise 
on the syndrome. As a result, it was the body fat that had a significant association with MetS in both 
men (p<0.0001) and women (p=0.004), and emerges as the crucial component to be targeted [94]. 
Hence, through the evidence cited, it appears that low calorie diets have the potency to cause a resultant 
decrease in various components of MetS.
Lifestyle modification
The term ‘Lifestyle’ implies the way of living. It encompasses the existence of individuals, families and 
societies with their corresponding behaviour in different settings such as physical, social, psycholo-
gical and economic [95]. With industrialization, emergence of lifestyle diseases is on the rise, owing 
to longer life span and faulty lifestyle. The resultant non-communicable and chronic diseases impose 
burden on the health services of a country especially the developing nations, leading to longer years 
of disability and death, eventually leading to poor productivity, and thus, hampering the growth of a 
nation [95]. Hence, interventions to promote healthy lifestyle to curb the development of MetS are the 
need of the hour (Table IV). Regular physical activity along with proper diet i.e. rich in fibre, low calorie 
or energy restricted, has shown beneficial effects in reduction of MetS [96], increase in the intake of 
fruits and vegetables [96,97], decrease in BMI, WC, triglycerides, LDL, insulin resistance [98-100] and 
inflammatory markers such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor-α 
(TNF-α) [99].
Most lifestyle intervention programs are based on weight reduction that has proved successful, demon-
strating significant improvements in all components of the syndrome [101-103].
Ref. Duration Sample Intervention Finding(s)
[96] 10 weeks N=50 overweight 
adults (n=22 
general 
educational 
group; n=28 high 
fibre nutrition 
group)
Lifestyle intervention focusing 
on physical activity and 
high fibre intake via dietary 
counselling and supervised 
exercise
 • Higher intake of fruits and vegetables, higher 
plasma β-carotene levels, greater reductions 
in body fat, waist circumference, obesity 
class III, obesity class II and 24% reduction of 
MetS was seen in the group 2 as compared 
to group 1
[97] 6 month 
intervention
N=816 male blue 
and white collar 
workers
Intervention consisted of 
individual counselling using 
motivational interviewing 
techniques, and was delivered 
by an occupational physician or 
occupational nurse
 • Statistically significant improvement in the 
snack (b-1.9, 95%CI = -3.7; -0.02) and fruit 
intake (b 1.7, 95%CI = 0.6; 2.9) at 6 months
 • Sustained snack and fruit intake improvement 
at 12 months
 • Beneficial impact on smoking (OR: 0.3) at 6 
months
 • No significant impact on leisure time 
physical activity
continues >
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A therapeutic lifestyle program (TLM) is the most sought after way of tackling the syndrome. A hospi-
tal based intervention consisting of a low calorie diet and regular aerobic physical activity was con-
ducted for 8 weeks in women (n=44) with MetS. Significant decrease in all MetS components except 
HDL-C, along with complete amelioration of the syndrome in 25% of women was observed [104]. 
Impact of TLM was also assessed among the rural women (n=32) with MetS who were randomized to 
a 4 week intervention consisting of health screening, education, exercise, diet and counselling, while a 
basic education booklet on MetS was provided to the control group. Significant reduction in the body 
weight, waist circumference, triglyceride levels, and positive behaviour change was noticed in the in-
tervention group compared to the control group (p<0.01). A positive time effect was noticed with the 
intervention group which resulted in decrement in the systolic blood pressure, fasting glucose, and 
LDL levels, and increment in the HDL levels, thus, substantiating the role of a TLM intervention in 
MetS improvement [105]. Another lifestyle intervention encompassing healthy diet evaluating the me-
tabolic and vascular changes that occur with the syndrome was carried out. Seventy five adults with 
MetS (30-55 years) were randomized to a 10,000-steps-a-day exercise program + healthy, no-sugar 
diet; a 3-times-a-week fitness (>75% peak VO2) program + healthy, no-sugar diet; and a 1-hour-
walking-a-day program + a tailored low-fat diet for 12 weeks. Significant increase in Flow Mediated 
Vasodilation and decrease in arterial pressure was maximum in the high intensity, no sugar group 
(p=0.036), wherein, arterial pressure decrease (p=0.0001) and weight loss (p=0.0001) was maintained 
post 1 year [106]. Similarly, a pilot study comprising 150 minutes of regular exercise, 200-300 kcal re-
duced daily diet for weight reduction, individual psycho-behavioural counselling based on Trans theo-
retical model and telephone coaching for behavioural modification, on 43 Korean adults with Type2 
DM and MetS proved to be beneficial (p<0.05) leading to better glycemic control, lessened CVD risk, 
and depression [107]. So, weight reduction seems to be a good strategy to target as a component of the 
syndrome that has the potential resulting in improvement of the other components of the syndrome.
Interventions at the genetic level
Role of genetics in the pathobiology of the syndrome, though small, is extremely significant [108]. 
Since MetS is an outcome of both environmental as well as genetic factors, a dietary intervention (12 
weeks) was undertaken in women (n=24) with the syndrome, to observe any change in the expression 
of LDL receptor and 3-hydroxy-3-methylglutarylcoenzymeA (HMG-CoA) reductase genes. Signifi-
cant decreases in WC (p<0.001), plasma triglycerides (p<0.05), systolic blood pressure (p<0.05), LDL-
C (p<0.01), plasma insulin (p<0.001), plasma TNF α (p<0.01), and homeostatic model assessment sco-
re for insulin resistance (HOMA-IR) (p<0.001) were observed post-intervention. Though no change in 
the LDL cholesterol gene expression was detected, reduction in HMG-CoA reductase gene expression 
(p<0.001) was observed [76]. This is an important finding as HMG-CoA reductase is the key regulatory 
gene in cholesterol synthesis that can ultimately lead to lowered very low density lipoprotein (VLDL) 
levels and correspondingly decrease LDL cholesterol. Modulation in the genetic expression of other 
genes have also been observed with a dietary intervention focusing on MeD in patients with MetS 
(n=20) and high CVD risk (n=49). It resulted in changes in the genetic expression of cyclooxygenases 
1 and 2, monocyte chemotactic protein 1, low-density lipoprotein (LDL) receptor-related gene, and 
pro-inflammatory genes. So, alongside environmental factors, an understanding of the genetic factors 
is also essential to customize treatment strategies [109].
Inflammation: an important component of intervention strategy
Several contributory factors such as abdominal obesity, dyslipidemia, impaired glucose tolerance, 
high blood pressure and prothrombotic state lead to the development of MetS [110]. Studies relating 
low-grade inflammation to MetS have been reported, with various biomarkers like increased C-reac-
tive protein (CRP), increased IL-6, increased TNF, decreased IL-10, decreased adiponectin, increased 
Ref. Duration Sample Intervention Finding(s)
[98] 6 months N = 60 (mean 
age 40.0 ± 8.5 
years) non-
alcoholic fatty 
liver disease 
(NAFLD) patients
Regular aerobic exercise for 30 
min/d, for at least 5d/week + 
Moderate Energy restricted diet 
containing 60% carbohydrate, 
20% fat, 20% protein and 
200mg cholesterol (NCEP Step 
I diet, (25 kcal/kg ideal body 
weight) was advised to patients 
with high BMI
 • Significant decrement in BMI, WC and 
Alanine amino Transferase (ALT) was 
observed post 6 months (p<0.01) in 45 
exercise compliant patients
 • No significant changes in BMI, WC and ALT 
were seen in 15 non-exercise compliant 
patients
[99] 3 week 
intervention 
+ 6 month 
follow-up
N= 14 (10 men, 
4 women, mean 
age 62.9 ± 6.9 
years) adults with 
MetS
Balanced diet corresponding to 
500 Kcal deficit vs. their daily 
energy expenditure (DEE) and 
they exercised 2 to 3 hours per 
day
 • Significant improvement in triglycerides, 
total, LDL and HDL cholesterol, insulin, 
leptin and adiponectin levels, CRP and pro-
inflammatory interleukines IL1, IL6 and TNF 
α were observed at 3 weeks
 • No changes in cytokines were observed
 • Changes were sustained at 6 months
[100] 1 year N=130 (37% 
African 
American) 
severely obese 
(class II or III) 
adults without 
diabetes
Group1: diet + physical activity 
12 months; group2: diet but 
physical activity only from 6 
months onwards)
 • Weight loss in group 1 was more significant 
as compared to group 2 at 6 months 
(p=0.02)
 • Similar weight loss in both groups at 12 
months (p=0.25)
 • Reductions in Waist circumference, visceral 
abdominal fat, hepatic fat content, blood 
pressure, and insulin resistance in both groups
[135] Ongoing N=4,600 
(5-40 years)
Intensive (3-monthly) lifestyle 
modification advice is superior 
to a less-intensive (12 monthly; 
control group) lifestyle 
modification advice
 • Ongoing trail: follow up post 5 years of 
intervention
 • Aims to reduce the prevalence of DM, Pre-
Diabetes and MetS
[136] Short-
term = 12 
weeks 
and long-
term = 24 
weeks
N=66 obese 
adolescents (41 
girls and 25 boys; 
BMI: 35.62 ± 
4.18 kg/m2)
Multidisciplinary lifestyle 
therapy composed of 
medical, dietary, exercise and 
psychological programs
 • Long term therapy resulted in decreased 
depression and binge eating symptoms, body 
image dissatisfaction, and improved QOL in 
girls (p<0.05)
 • Reduced anxiety trait/state, symptoms of 
binge eating and improvement in QOL was 
observed in boys (p<0.05)
[137] 12 week N=49 (aged 25-
80 years) MED 
(n=19); PED 
(n=25)
MED-Mediterranean-style, 
low glycemic load diet group; 
Phytochemical enriched diet 
(PED)-Mediterranean diet + 
phytochemicals
 • Weight loss was achieved in both groups
 • More significant reductions in the cholesterol 
levels, triglycerides, cholesterol/HDL and 
TG/HDL ratio was observed in PED group 
(p<0.05) compared to MED
 • Increased HDL(p < 0.05), decreased TG/
HDL(p < 0.01),and resolution of more 
number of patients (43%) from MetS was 
seen only in the PED group
[138] 12 weeks N= 59(n=20 WL; 
n=20 WL+EX; 
n=19 control)
dietary weight loss (WL, 
n=20); dietary weight loss and 
moderate-intensity aerobic 
exercise (WL+EX, n=20); no 
treatment (n=19)
 • Decrement in body weight (P < 0.001), 
Resting SNS activity (p<0.01), muscle 
sympathetic nerve activity (p<0.01) was 
observed in both WL and WL+EX group
 • Increment in fitness levels were seen only in 
WL+EX group (P< 0.001)
Table IV. Role of Lifestyle interventions (RCTs) in combating MetS and its components
ALT = Alanine Amino Transferase; BMI = Body Mass Index; CRP = C Reactive Protein; DEE = Daily Energy 
Expenditure; DM = Diabetes Mellitus; EX = Exercise; HDL = High Density Lipoprotein; IL-1 = Interleukin 1; 
IL-2 = Interleukin 2; LDL = Low Density Lipoprotein; MetS = Metabolic Syndrome; NAFLD = Non-Alcoholic 
Fatty Liver Disease; PED = Phytochemical Enriched Diet; QOL = Quality of Life; SNS = Sympathetic Nervous 
System; TG = Triglycerides;TNFα = Tumor Necrosis Factor α; WC = Waist Circumference; WL = Weight Loss
> follows 
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A therapeutic lifestyle program (TLM) is the most sought after way of tackling the syndrome. A hospi-
tal based intervention consisting of a low calorie diet and regular aerobic physical activity was con-
ducted for 8 weeks in women (n=44) with MetS. Significant decrease in all MetS components except 
HDL-C, along with complete amelioration of the syndrome in 25% of women was observed [104]. 
Impact of TLM was also assessed among the rural women (n=32) with MetS who were randomized to 
a 4 week intervention consisting of health screening, education, exercise, diet and counselling, while a 
basic education booklet on MetS was provided to the control group. Significant reduction in the body 
weight, waist circumference, triglyceride levels, and positive behaviour change was noticed in the in-
tervention group compared to the control group (p<0.01). A positive time effect was noticed with the 
intervention group which resulted in decrement in the systolic blood pressure, fasting glucose, and 
LDL levels, and increment in the HDL levels, thus, substantiating the role of a TLM intervention in 
MetS improvement [105]. Another lifestyle intervention encompassing healthy diet evaluating the me-
tabolic and vascular changes that occur with the syndrome was carried out. Seventy five adults with 
MetS (30-55 years) were randomized to a 10,000-steps-a-day exercise program + healthy, no-sugar 
diet; a 3-times-a-week fitness (>75% peak VO2) program + healthy, no-sugar diet; and a 1-hour-
walking-a-day program + a tailored low-fat diet for 12 weeks. Significant increase in Flow Mediated 
Vasodilation and decrease in arterial pressure was maximum in the high intensity, no sugar group 
(p=0.036), wherein, arterial pressure decrease (p=0.0001) and weight loss (p=0.0001) was maintained 
post 1 year [106]. Similarly, a pilot study comprising 150 minutes of regular exercise, 200-300 kcal re-
duced daily diet for weight reduction, individual psycho-behavioural counselling based on Trans theo-
retical model and telephone coaching for behavioural modification, on 43 Korean adults with Type2 
DM and MetS proved to be beneficial (p<0.05) leading to better glycemic control, lessened CVD risk, 
and depression [107]. So, weight reduction seems to be a good strategy to target as a component of the 
syndrome that has the potential resulting in improvement of the other components of the syndrome.
Interventions at the genetic level
Role of genetics in the pathobiology of the syndrome, though small, is extremely significant [108]. 
Since MetS is an outcome of both environmental as well as genetic factors, a dietary intervention (12 
weeks) was undertaken in women (n=24) with the syndrome, to observe any change in the expression 
of LDL receptor and 3-hydroxy-3-methylglutarylcoenzymeA (HMG-CoA) reductase genes. Signifi-
cant decreases in WC (p<0.001), plasma triglycerides (p<0.05), systolic blood pressure (p<0.05), LDL-
C (p<0.01), plasma insulin (p<0.001), plasma TNF α (p<0.01), and homeostatic model assessment sco-
re for insulin resistance (HOMA-IR) (p<0.001) were observed post-intervention. Though no change in 
the LDL cholesterol gene expression was detected, reduction in HMG-CoA reductase gene expression 
(p<0.001) was observed [76]. This is an important finding as HMG-CoA reductase is the key regulatory 
gene in cholesterol synthesis that can ultimately lead to lowered very low density lipoprotein (VLDL) 
levels and correspondingly decrease LDL cholesterol. Modulation in the genetic expression of other 
genes have also been observed with a dietary intervention focusing on MeD in patients with MetS 
(n=20) and high CVD risk (n=49). It resulted in changes in the genetic expression of cyclooxygenases 
1 and 2, monocyte chemotactic protein 1, low-density lipoprotein (LDL) receptor-related gene, and 
pro-inflammatory genes. So, alongside environmental factors, an understanding of the genetic factors 
is also essential to customize treatment strategies [109].
Inflammation: an important component of intervention strategy
Several contributory factors such as abdominal obesity, dyslipidemia, impaired glucose tolerance, 
high blood pressure and prothrombotic state lead to the development of MetS [110]. Studies relating 
low-grade inflammation to MetS have been reported, with various biomarkers like increased C-reac-
tive protein (CRP), increased IL-6, increased TNF, decreased IL-10, decreased adiponectin, increased 
Ref. Duration Sample Intervention Finding(s)
[98] 6 months N = 60 (mean 
age 40.0 ± 8.5 
years) non-
alcoholic fatty 
liver disease 
(NAFLD) patients
Regular aerobic exercise for 30 
min/d, for at least 5d/week + 
Moderate Energy restricted diet 
containing 60% carbohydrate, 
20% fat, 20% protein and 
200mg cholesterol (NCEP Step 
I diet, (25 kcal/kg ideal body 
weight) was advised to patients 
with high BMI
 • Significant decrement in BMI, WC and 
Alanine amino Transferase (ALT) was 
observed post 6 months (p<0.01) in 45 
exercise compliant patients
 • No significant changes in BMI, WC and ALT 
were seen in 15 non-exercise compliant 
patients
[99] 3 week 
intervention 
+ 6 month 
follow-up
N= 14 (10 men, 
4 women, mean 
age 62.9 ± 6.9 
years) adults with 
MetS
Balanced diet corresponding to 
500 Kcal deficit vs. their daily 
energy expenditure (DEE) and 
they exercised 2 to 3 hours per 
day
 • Significant improvement in triglycerides, 
total, LDL and HDL cholesterol, insulin, 
leptin and adiponectin levels, CRP and pro-
inflammatory interleukines IL1, IL6 and TNF 
α were observed at 3 weeks
 • No changes in cytokines were observed
 • Changes were sustained at 6 months
[100] 1 year N=130 (37% 
African 
American) 
severely obese 
(class II or III) 
adults without 
diabetes
Group1: diet + physical activity 
12 months; group2: diet but 
physical activity only from 6 
months onwards)
 • Weight loss in group 1 was more significant 
as compared to group 2 at 6 months 
(p=0.02)
 • Similar weight loss in both groups at 12 
months (p=0.25)
 • Reductions in Waist circumference, visceral 
abdominal fat, hepatic fat content, blood 
pressure, and insulin resistance in both groups
[135] Ongoing N=4,600 
(5-40 years)
Intensive (3-monthly) lifestyle 
modification advice is superior 
to a less-intensive (12 monthly; 
control group) lifestyle 
modification advice
 • Ongoing trail: follow up post 5 years of 
intervention
 • Aims to reduce the prevalence of DM, Pre-
Diabetes and MetS
[136] Short-
term = 12 
weeks 
and long-
term = 24 
weeks
N=66 obese 
adolescents (41 
girls and 25 boys; 
BMI: 35.62 ± 
4.18 kg/m2)
Multidisciplinary lifestyle 
therapy composed of 
medical, dietary, exercise and 
psychological programs
 • Long term therapy resulted in decreased 
depression and binge eating symptoms, body 
image dissatisfaction, and improved QOL in 
girls (p<0.05)
 • Reduced anxiety trait/state, symptoms of 
binge eating and improvement in QOL was 
observed in boys (p<0.05)
[137] 12 week N=49 (aged 25-
80 years) MED 
(n=19); PED 
(n=25)
MED-Mediterranean-style, 
low glycemic load diet group; 
Phytochemical enriched diet 
(PED)-Mediterranean diet + 
phytochemicals
 • Weight loss was achieved in both groups
 • More significant reductions in the cholesterol 
levels, triglycerides, cholesterol/HDL and 
TG/HDL ratio was observed in PED group 
(p<0.05) compared to MED
 • Increased HDL(p < 0.05), decreased TG/
HDL(p < 0.01),and resolution of more 
number of patients (43%) from MetS was 
seen only in the PED group
[138] 12 weeks N= 59(n=20 WL; 
n=20 WL+EX; 
n=19 control)
dietary weight loss (WL, 
n=20); dietary weight loss and 
moderate-intensity aerobic 
exercise (WL+EX, n=20); no 
treatment (n=19)
 • Decrement in body weight (P < 0.001), 
Resting SNS activity (p<0.01), muscle 
sympathetic nerve activity (p<0.01) was 
observed in both WL and WL+EX group
 • Increment in fitness levels were seen only in 
WL+EX group (P< 0.001)
Table IV. Role of Lifestyle interventions (RCTs) in combating MetS and its components
ALT = Alanine Amino Transferase; BMI = Body Mass Index; CRP = C Reactive Protein; DEE = Daily Energy 
Expenditure; DM = Diabetes Mellitus; EX = Exercise; HDL = High Density Lipoprotein; IL-1 = Interleukin 1; 
IL-2 = Interleukin 2; LDL = Low Density Lipoprotein; MetS = Metabolic Syndrome; NAFLD = Non-Alcoholic 
Fatty Liver Disease; PED = Phytochemical Enriched Diet; QOL = Quality of Life; SNS = Sympathetic Nervous 
System; TG = Triglycerides;TNFα = Tumor Necrosis Factor α; WC = Waist Circumference; WL = Weight Loss
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leptin, increased Serum Amyloid A (SAA), increased resistin and increased Plasminogen Activator 
Inhibitor-1(PAI-1) being responsible for it [111]. Chronic low-grade inflammation is associated with 
insulin resistance. One of the main components of the inflammatory process is cytokines, particularly, 
IL-1, TNF and IL-6, of which IL-6 is the central mediator of inflammatory response. Its relationship 
with insulin, mediated through adiposity, links it to MetS. Another proinflammatory cytokine viz. 
TNF, secreted to a large extent by adipocytes, is an important regulator of insulin sensitivity, which 
decreases with weight loss. Besides these, other markers such as adiponectins are also associated with 
MetS [111]. Interventions to target MetS have shown an impact on its markers such as circulating adi-
ponectin. Forty four obese adolescent obese girls (13-15 years), who were randomized to a lifestyle plus 
exercise intervention group (LIFE+EX, n = 22) or control (CON, n = 22) for 12 weeks, resulted in im-
provements in body composition, waist circumference, waist-to-hip ratio, and significant reductions in 
blood pressure, triglycerides, LDL levels, glucose, insulin, HOMA-IR, CRP, and leptin compared to the 
controls. However, no change was observed in the circulating adiponectin levels [112]. Metabolic alte-
rations associated with MetS particularly, decrement in the levels of metabolic variables and CRP va-
lues were gauged for their affiliation with diet/exercise variation. In a prospective randomized control 
trial of 169 cases and 166 controls [113], exercise levels were inversely associated with CRP (p<0.001), 
as fibre intake was with fasting glucose (p<0.001), independent of weight reduction. Changes in the 
C-reactive protein with either a low fat diet or physical activity or both was demonstrated among men 
(n=149) and post menopausal women (n=125) in a 1 year RCT. Significant changes in CRP in both diet 
+ physical activity group was more than physical activity group only (p=0.02). Any diet treatment with 
or without physical activity also had greater CRP change than the control (p=0.001), thus, demonstra-
ting the efficacy of a low fat diet for reduction of the syndrome [94].
A recent review proposed the role of interleukin-18 (IL-18) in the pathogenesis of diabetes and MetS, 
as a predictor of cardio-vascular events and mortality. IL-18 results in induction of inflammatory reac-
tions being present in the adipose tissue, atherosclerotic plaque and in the muscle tissue, therefore, can 
act as a marker of chronic low-grade inflammation [114]. The association of MetS with beta 3-adrener-
gic receptor (ADRB3) Trp64Arg polymorphism was examined in 36 male employees with MetS (avera-
ge age, 49 ± 6 years old) undergoing a three month intervention. There was 53.8% improvement in the 
MetS post intervention in participants with ADRB3 Trp64Arg polymorphism, supporting its role in in-
fluencing the syndrome coupled with an exercise-based intervention program [115]. The relationship 
of inflammatory markers and their possible role in the pathogenesis of MetS have a unique prospect 
in combating the syndrome as various repercussions associated with the syndrome are correlated with 
them. Development of cost-effective strategies for evaluation of these markers needs to be done so that 
they can be used for prevention as well as treatment of the syndrome.
Early intervention: need of the hour
Early interventions have a better potential of targeting the syndrome than doing it at a later stage, where 
much improvement cannot occur. A multidisciplinary school based intervention can be a promising 
strategy [116]. This was carried out in overweight and obese adolescents (n=37 intervention group; 
n=39 control; age: 17.3±1.3 years; BMI: 29.5±3.7 kg/m2) who were encouraged to adopt a healthy li-
festyle, coupled with consultations from dieticians and physiotherapists, and a free membership to a 
nearby fitness centre. After 6 months of intervention significant weight loss (p<0.001), change in BMI 
(p<0.001), decrement in WC (p=0.011) and fasting glucose (p=0.005) was observed compared to the 
control group, thus, guaranteeing the usefulness of a multi disciplinary intervention program [117]. 
Rarity of lifestyle interventions in obese children leads to the possibility of development of MetS in 
future. Obesity and overweight in children can thus, have serious ramifications if not controlled sooner 
enough projecting to high risk for development of MetS and subsequent CVD in adulthood [118,119]. 
A lifestyle intervention with obese children (n=288 intervention group; n=186 control group) led to a 
221Reviews in Health Care 2013; 4(4)© SEEd All rights reserved
I. Kataria, R. Chadha, R. PathakDietary and lifestyle modification in metabolic syndrome: a review of randomized control trials in different population groups
significant decrease in BMI, WC, oral glucose tolerance test (OGTT) values, blood pressure and MetS 
prevalence in the intervention group as compared to controls [120]. A rigorous lifestyle intervention, 
in which a high-fibre, low-fat diet in a 2-week residential program where food was provided ad libitum, 
and daily aerobic exercise was performed, was carried out in 16 overweight and obese subjects. Post 2 
weeks of intervention, significant decrement in insulin level (p<0.01), HOMA insulin level (p<0.05), 
body weight (p<0.01), total cholesterol (p<0.01), LDL (p<0.01), triglycerides (p<0.01), LDL/HDL ratio 
(p<0.01), systolic blood pressure (p<0.001) and diastolic blood pressure (p=0.01); however, no change 
was observed in HDL-C levels. Of the 7 patients who were diagnosed with MetS, the syndrome rever-
sed in all of them [121].
Evidence generation from intervention 
trials: development of public policies
For development and improvement of the public policies, evidence generated through intervention 
trials holds the key. However, sustainability is an important issue with respect to most interventional 
studies which falter in the long run because of poor compliance and low cohesion rates [122-125]. 
Restrictions in diet only serve the purpose as long as they aren’t overtly limiting; as chances of rebound 
and the intensification of the appetite with reference to too many restricted foods isn’t inevitable [126]. 
It holds the key to behaviour change in confronting MetS. Though, intensive, individualized lifestyle 
intervention programs are the most appropriate step for increasing sustainability; cost and time are li-
mited [127]. A 16 week group based intervention, economical in terms of cost and time was formulated 
for 153 obese/overweight individuals focusing on dietary and physical activity information, behaviou-
ral self management tools, food label reading, supermarket tour and cooking, exercise sessions and 
peer group support. Usefulness of various components of the intervention was reported by participants 
in the intervention group compared to controls. Such programs bring out the need of active training in 
lifestyle modification rather than passive provision of guidelines in the form of a booklet. Weight loss 
and weight maintenance are two important concepts that go hand in hand. Weight loss alone can’t be 
the criteria for tackling MetS, because if the lost weight is not sustained chances of rebounding is high 
[128]. Weight loss maintenance in an intervention (n=14 males; 4 females) resulted stable energy ba-
lance affected sympathetic nervous system activity leading to decrement in nor epinephrine spill over 
rate (p=0.004), muscle sympathetic nerve activity (p<0.001), and plasma rennin activity (p=0.007), 
and increment in baroreflex sensitivity (p=0.005). Compliance and adherence are two substantial per-
spectives that need to be addressed whenever lifestyle intervention programs are implemented for syn-
drome’s reduction. Though there have been studies regarding the implementation of these programs, 
sustainability is the issue that has been neglected often. Therefore, approaches to increase sustainability 
are required for combating the syndrome effectively [129]. With substantial health consequences, it 
becomes all the more important that MetS needs to be targeted, and physical activity along with diet 
improvement is one such measure that has the ability to attenuate the syndrome if performed metho-
dically [96,128,130].
Conclusion
With westernization of the worldwide dietary pattern, MetS is reaching epidemic proportions, whe-
rein, diet and lifestyle interventions are regarded as the first line of defence for combating it [131]. The 
consequences of globalization and industrialization are the emergence of lifestyle related NCDs contri-
buted by unhealthy dietary patterns, lack of physical activity and smoking as well as alcohol abuse. 
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With only a handful of people following the healthy diet and lifestyle, majority still fall in the bracket 
of those with compromised diet and lifestyle, burdening the health services [95]. Socio economic chan-
ges and eventually globalization has led to transformation in the society. This has led to alterations in 
the dietary habits eventually resulting in nutrition transition [132]. A first line intervention targeting 
MetS involves dietary and lifestyle modification with regular physical activity over a period of time. 
However, improvement in MetS parameters can only be maintained when these modifications can be 
sustained. This requires multiple follow up sessions post-intervention rather than one counselling ses-
sion involving the use of several behavioural techniques to improve compliance [133]. For development 
and improvement of the public policies, evidence generated through intervention trials holds the key. 
Therefore, dietary and lifestyle modification in continuum is required to overcome MetS holistically.
References
1. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in develo-
ping countries. Nutr Rev 2012; 70: 3-21; http://dx.doi.org/10.1111/j.1753-4887.2011.00456.x
2. Misra A, Singhal N, Sivakumar B, et al. Nutrition transition in India: Secular trends in dietary in-
take and their relationship to diet-related non-communicable diseases. J Diabetes 2011; 3: 278-92; 
http://dx.doi.org/10.1111/j.1753-0407.2011.00139.x
3. Misra A. Overnutrition and nutritional deficiency contribute to metabolic syndrome and 
atherosclerosis in Asian Indians. Nutrition 2002; 18: 702-3; http://dx.doi.org/10.1016/S0899-
9007(02)00818-3
4. Reddy KS. Cardiovascular diseases in the developing countries: dimensions, determinants, dyna-
mics and directions for public health action. Public Health Nutr 2002; 5: 231-7; http://dx.doi.
org/10.1079/PHN2001298
5. Murray CJL, Lopez AD. The global burden of disease. Boston: Harvard School of Public Health, 
1996
6. World Health Organization. The World Health Report: life in the 21st century: A vision for all. 
Geneva: World Health Organization, 1998
7. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance in India. In: Gan D. Diabetes 
atlas, 3rd ed. Kortrijik (Hevle), Belgium: International Diabetes Federation 2006; 15-103
8. Pritchett AM, Foreyt JP, Mann DL. Treatment of the Metabolic Syndrome: The Impact of Lifestyle 
Modification. Curr Atheroscler Rep 2005; 7: 95-102; http://dx.doi.org/10.1007/s11883-005-0030-4
9. Modan M, Halkin H, Almog S, et al. Hyperinsulinaemia - A link between hypertension, obesity 
and glucose intolerance. J Clin Invest 1985; 75: 809-17; http://dx.doi.org/10.1172/JCI111776
10. Ferrannini E, Haffner M, Mitchell BD, et al. Hyperinsulinaemia: the key feature of a cardiovascular 
and metabolic syndrome. Diabetologia 1991; 34: 416-22; http://dx.doi.org/10.1007/BF00403180
11. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607; http://
dx.doi.org/10.2337/diab.37.12.1595
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and 
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the 
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Tre-
atment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 
2002; 106: 3143-421; http://circ.ahajournals.org/content/106/25/3143.citation
13. Do Carmo I, Dos Santos O, Camolas J, et al. Overweight and obesity in Portugal: National preva-
lence in 2003-2005. Obes Rev 2008; 9: 11-9; http://dx.doi.org/10.1111/j.1467-789X.2007.00422.x
14. Hollman G, Kristenson M. The prevalence of the metabolic syndrome and its risk factors in a 
middle-aged Swedish population–mainly a function of overweight? Eur J Cardiovasc Nurs 2008; 7: 
21-6; http://dx.doi.org/10.1016/j.ejcnurse.2007.05.003
15. Hillier TA, Fagot-Campagna A, Eschwege E, et al. Weight change and changes in the metabolic 
syndrome as the French population moves towards overweight: The D.E.S.I.R. cohort. Int J Epide-
miol 2006; 35: 190-6; http://dx.doi.org/10.1093/ije/dyi281
16. Ervin RB. Prevalence of Metabolic Syndrome among Adults 20 Years of Age and Over, by Sex, Age, 
Race and Ethnicity, and Body Mass Index: United States, 2003-2006. National Health Statistics 
Reports. Hyattsville, MD: National Center for Health Statistics 2009, No. 13
The review in brief
Clinical question Dietary and lifestyle modification has been underlined as the first treatment to combat Metabolic 
Syndrome by AHA. The present review analyzes the role of dietary and lifestyle modification as an 
effective strategy to reduce the syndrome.
Type of review Narrative
Search of the 
literature
Medline, PubMed (National Library of Medicine, Bethesda, MD, USA), Cochrane Library, Science 
Direct and Google Scholar search using the following keywords: Metabolic Syndrome, diet, 
lifestyle, Mediterranean diet, intervention, insulin resistance, obesity, non- communicable diseases, 
hypertension, HDL, triglycerides, inflammation, genetics, CRP
Conclusions The present review concludes that:
 • MetS is a complex entity that is a result of multitude of factors.
 • Dietary and lifestyle modification is the first line of treatment for prevention of the syndrome.
 • Mediterranean and low calorie diets have the potency to cause a resultant decrease in various 
components of MetS.
 • Regular physical activity along with diet improvement has the ability to attenuate the syndrome if 
performed methodically.
 • Weight reduction resulting from dietary and lifestyle modification has proven beneficial in combating 
the syndrome.
 • Alongside environmental factors, an understanding of the genetic factors and inflammatory markers 
is also essential to customize treatment strategies.
 • Early interventions have a better potential of targeting the syndrome than doing it at a later stage, 
where much improvement cannot occur.
Limitations Though various studies involving dietary and lifestyle modification have shown benefits by resulting in 
the improvement of various components of the syndrome, the emphasis needs to be laid on carrying 
out research that ultimately looks at the sustainability and compliance with such interventions, in order 
to show their efficacy on a long-term basis.
Future directions for research
Future studies should be undertaken focusing on carrying out interventions (diet and lifestyle) 
among young adults in whom the prevalence of the syndrome might be low but have a great 
potential of developing it in future if no action is taken early. Development of appropriate stra-
tegies to increase the sustainability of these interventions must be accomplished to combat the 
syndrome. The diagnosis and severity of the syndrome should be based on uniform diagnostic 
criteria considering population, country and ethnicity. Since, there are a multitude of risk factors 
that eventually lead to MetS, longitudinal studies should be conducted to understand the inte-
raction among these factors. Future studies should concentrate on determining a suitable dietary 
composition that could be considered as a template for alleviation of the syndrome. Special at-
tention needs to be drawn on genetics as well as inflammatory markers such as IL, CRP, adrena-
gic receptors etc, which can be used in the development of cost-effective strategies for preven-
tion and treatment of MetS.
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sion involving the use of several behavioural techniques to improve compliance [133]. For development 
and improvement of the public policies, evidence generated through intervention trials holds the key. 
Therefore, dietary and lifestyle modification in continuum is required to overcome MetS holistically.
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